Depomed, Inc. Gains Greater Access To Global Pharmaceutical Companies Through Collaboration Agreement With Patheon

MENLO PARK, Calif.--(BUSINESS WIRE)--Aug. 7, 2006--Depomed, Inc. (NASDAQ:DEPO - News) announced today that it has signed a collaboration agreement with Patheon Inc. (TSX:PTI - News), a leading global provider of development and manufacturing services in the pharmaceutical industry, related to Depomed's proprietary AcuForm(TM) drug delivery technology.

Back to news